23andMe is selling everyone’s DNA to the pharmaceutical industry. Yes, that includes your personal information if you are a 23andMe customer.

GSK Plc will pay 23andMe Holding Co. $20 million for access to the genetic-testing company’s vast trove of consumer DNA data, extending a five-year collaboration that’s allowed the drugmaker to mine genetic data as it researches new medications.

Details can be found at: https://boingboing.net/2023/10/30/23andme-to-sell-dna-records-to-drug-company.html.